Abby Bronson's Blog – October 2016 Archive (1)
Duchenne Research Update: October 2016
When I first joined the Duchenne community in 2009 at Children’s National Medical Center, I remember thinking that I was walking into a critical juncture in Duchenne history. There were three compounds in the clinic (drisapersen, ataluren, and eteplirsen aka Exondys 51) with more waiting in the wings to go into clinical trials, a drug…
ContinueAdded by Abby Bronson on October 18, 2016 at 1:00pm — No Comments
Latest Blog Posts
- Your gift helps PPMD expand gene therapy
- PPMD Research Update: Gene Therapy, Accelerating Clinical Trials & More
- Accelerating the Clinical Trial Process in Duchenne
- Gene Transfer in the Spotlight
- Webinar Q&A: Gene Therapy Part 2 – Nationwide Children's Hospital
- PPMD Research Update: September 2017
- FDA Announces Approval of First Gene Therapy in the United States
Most Popular Blog Posts
- PPMD Announces Gene Therapy Forum
- Newly Published Data Validates Micro-Dystrophin Gene Therapy Approach in Animal Model for Duchenne
- Duchenne Research Update: October 2016
- Duchenne Research Update: February 2017
- Accelerating the Clinical Trial Process in Duchenne
- Understanding Gene Therapy & CRISPR/Cas9
- Update on Gene Replacement/Repair Strategies for Duchenne Muscular Dystrophy
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
